Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Risk Factors For Tuberculosis In Dialysis Patients: A Prospective Multi-center Clinical Trial

A. Christopoulos, A. Diamantopoulos, P. Dimopoulos, D. S. Goumenos, G. Barbalias
Published 2009 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
BackgroundProfound alterations in immune responses associated with uraemia and exacerbated by dialysis increase the risk of developing active tuberculosis (TB) in chronic haemodialysis patients (HDPs). In the current study, was determined the impact of various risk factors on TB development. Our aim was to identify which HDPs need anti-TB preventive therapy.MethodsProspective study of 272 HDPs admitted, through a 36-month period, to our institutions. Specific Relative Risk (RR) for TB was estimated, considering age matched subjects from the general population as reference group. Entering the study all patients were tested with tuberculin (TST). Using Cox's proportional hazard model the independent effect of various risk factors associated with TB development was estimated.ResultsHistory of TB, dialysis efficiency, use of Vitamin D supplements, serum albumin and zinc levels were not proved to influence significantly the risk for TB, in contrast to: advanced age (>65 years), BMI, diabetes mellitus, tuberculin reactivity, healed TB lesions on chest X-ray and time on dialysis. Elderly (>70 years old) HDPs (Adjusted RR 25.3, 95%CI 20.4-28.4, P < 0.02), diabetics (Adj.RR 25.3, 95%CI 17.2-21.1, P < 0.03), underweighted (Adj.RR 72.3, 95%CI 65.2-79.8 P < 0.001), tuberculin responders (Adj.RR 41.4, 95%CI 37.9-44.8, P < 0.03), HDPs with fibrotic lesions on chest x-ray (Adj.RR 82.3, 95%CI 51.3-95.5, P < 0.03) and those treated with haemodialysis for < 12 months (Adj.RR 110.0, 95%CI 97.4-135.3, P < 0.001), presented significantly higher specific RR for TB even after adjusting for the effect of the remaining studied risk factors.ConclusionThe above mentioned factors have to be considered by the clinicians, evaluating for TB in HDPs. Positive TST, the existence of predisposing risk factors and/or old TB lesions on chest X-ray, will guide the diagnosis of latent TB infection and the selection of those HDPs who need preventive chemoprophylaxis.
This paper references
10.1164/RCCM.167.4.603
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.
H. Blumberg (2003)
10.1016/S0002-9343(89)80625-4
Antiphospholipid antibodies and Sneddon's syndrome.
J. A. Vargas (1989)
controlling tuberculosis in the United States : American Thoracic Society / Centers for Disease Control and Prevention / Infectious Diseases Society of America
A Christopoulos (2005)
Iwasaki H: Problems about the management of active pulmonary tuberculosis patients undergoing haemodialyis
H Tamioka (2003)
10.1378/CHEST.116.4.961
Does aging modify pulmonary tuberculosis?: A meta-analytical review.
C. Pérez-Guzmán (1999)
Risk of tuberculosis in dialysis patients: association of initial tuberculin and 2,4-dinitrochlorobenzene sensitivity with risk of tuberculosis
A Christopoulos (2006)
Problems about the management of active pulmonary tuberculosis patients undergoing haemodialyis
H Tamioka (2003)
10.1016/S0084-3873(08)70174-3
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States.
L. Tanoue (2005)
[Risk factors for developing tuberculosis].
V. Škodrić-Trifunović (2004)
A new old problem.
G. Turnbull (2004)
Isoniazid-related fatal hepatitis.
P. Millard (1996)
Regression models and life tables (with discussion
D. Cox (1972)
10.1007/s11255-006-9051-3
Risk of tuberculosis in dialysis patients: association of tuberculin and 2,4-dinitrochlorobenzene reactivity with risk of tuberculosis
A. Christopoulos (2006)
Diagnosis and prevention of tuberculosis in hemodialysis patients. a new old problem? Nefrologia
M J Aladren (2004)
10.11400/KEKKAKU1923.78.353
[Problems about the management of active pulmonary tuberculosis patients undergoing haemodialysis--our experiences and nation-wide questionnaire survey].
H. Tomioka (2003)
10.1097/00041552-199311000-00005
The immune system in end-stage renal disease.
B. Descamps-Latscha (1993)
Succesful therapy of tuberculosis in dialysis patients
Hormany Mohammed (1997)
10.4049/jimmunol.167.9.5217
Direct Ex Vivo Analysis of Antigen-Specific IFN-γ-Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment1
Ansar A. Pathan (2001)
The role of palpation technique
D Bouros (1992)
The correlation of clinical and radiological appearance of metastatic calcifications in patients undergoing dialysis
A Christopoulos
10.1159/000065031
Tuberculin Skin Test and Anergy in Dialysis Patients of a Tuberculosis-Endemic Area
H. Fang (2002)
[Diagnosis and prevention of tuberculosis in hemodialysis patients. a new old problem?].
M. Aladrén (2004)
10.1111/j.1542-4758.2006.00130.x
Tuberculosis in end‐stage renal disease patients on hemodialysis
Mohammad Abdelrahman (2006)
10.1016/0002-9343(79)90240-7
Tuberculosis in patients undergoing maintenance hemodialysis.
A. Lundin (1979)
Diagnosis and prevention of tuberculosis in hemodialysis patients. a new old problem
Aladrén Mj (2004)
10.1093/NDT/14.12.2857
Tuberculosis prophylaxis for the chronically dialysed patient--yes or no?
A. Korzets (1999)
Association of initial tuberculin sensitivity, age and sex with the incidence of tuberculosis in south India: a 15-year follow-up.
S. Radhakrishna (2003)
[Diagnostic and therapeutic features of tuberculosis in patients undergoing maintenance hemodialysis in Dakar].
A. Niang (2005)
10.1159/000169068
Successful therapy of tuberculosis in hemodialysis patients.
M. Al-homrany (1997)
10.1164/ARTPD.1957.76.4.517
Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build.
C. Palmer (1957)
10.1186/1471-2458-7-234
Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence
C. Stevenson (2007)
The risk of tuberculosis in patients with fibrous lesions radiographically diagnosed
P Steinbruck (1972)
Diagnostic and therapeutic features of tuberculosis in patients undergoing maintenance haemodialysis in Dakar
A Niang (2005)
10.1164/AJRCCM.163.4.2009100
Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.
A. Lalvani (2001)
10.1081/JDI-65379
Tuberculin Skin Test Results and the Booster Phenomenon in Two-Step Tuberculin Skin Testing in Hemodialysis Patients
E. Doğan (2005)
10.1016/S0954-6111(06)80059-4
The role of inexperience in measuring tuberculin skin reaction (Mantoux test) by the pen or palpation technique.
D. Bouros (1992)
10.1093/NDT/GFL488
Risk factors for Mycobacterium tuberculosis in US chronic dialysis patients.
M. Klote (2006)
10.1111/J.1523-1755.2004.00586.X
Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients.
M. Sester (2004)
10.1378/CHEST.99.2.416
Palpation vs pen method for the measurement of skin tuberculin reaction (Mantoux test).
D. Bouros (1991)
10.2105/AJPH.87.4.574
The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics.
A. Pablos-Mendez (1997)
The correlation of clinical and radiological appearance of metastatic calcifications in patients undergoing dialysis [abstract
A Christopoulos (2002)
Succesful therapy of tuberculosis in dialysis patients
Hormany Mohammed Al (1997)
10.1093/NDT/GFG569
The value of tuberculin skin testing in haemodialysis patients.
A. Wauters (2004)
10.1016/J.AJIC.2005.12.003
Boosted tuberculin skin testing in hemodialysis patients.
K. Cengiz (2006)
Tuberculosis and chronic renal disease.
M. Hussein (2002)
TM: Diagnostic and therapeutic features of tuberculosis in patients undergoing maintenance haemodialysis in Dakar
A Niang (2005)



This paper is referenced by
10.1371/journal.pone.0064563
Tuberculin Skin Test and Boosted Reactions among Newly Employed Healthcare Workers: An Observational Study
S. C. Kim (2013)
Infection-triggered haemophagocytic lymphohistiocytosis
S. Costerus (2019)
10.1093/ofid/ofz313
Radiological Signs of Latent Tuberculosis on Chest Radiography: A Systematic Review and Meta-Analysis
J. W. Uzorka (2019)
10.4172/2155-6156.1000170
Role of Diabetes in prevalence of Tuberculosis
Aliya Naaz Siddiqui (2012)
10.1016/j.jmii.2018.05.003
Three months of rifapentine and isoniazid for latent tuberculosis infection in hemodialysis patients: High rates of adverse events.
S. Lin (2019)
10.1016/j.clim.2016.05.004
Maintenance of Mycobacterium tuberculosis-specific T cell responses in End Stage Renal Disease (ESRD) and implications for diagnostic efficacy.
J. Juno (2016)
10.3390/diagnostics11040595
Cytokine and Chemokine mRNA Expressions after Mycobacterium tuberculosis-Specific Antigen Stimulation in Whole Blood from Hemodialysis Patients with Latent Tuberculosis Infection
Ji Young Park (2021)
10.1155/2019/1297131
Expression of USP18 and IL2RA Is Increased in Individuals Receiving Latent Tuberculosis Treatment with Isoniazid
Eleane de Oyarzabal (2019)
10.1258/ebm.2010.010061
Vitamin D and host resistance to infection? Putting the cart in front of the horse
Danny W. Bruce (2010)
10.3390/tropicalmed4020085
Latent Tuberculosis Infection among Healthcare Workers in Duhok Province: From Screening to Prophylactic Treatment
Hind Bahzad Almufty (2019)
10.1159/000360183
Epidemiology of Tuberculosis Cases with End-Stage Renal Disease, California, 2010
A. Chitnis (2014)
10.1016/j.ijtb.2018.06.004
Efficacy and safety of cholecalciferol-augmented anti-tuberculosis therapy for treatment of naïve patients with pulmonary tuberculosis: A randomized, controlled, clinical study.
A. Hasanain (2019)
10.1186/1756-0500-5-311
The epidemiology of tuberculosis in Phuentsholing General Hospital: a six-year retrospective study
Kinley Wangdi (2011)
10.1590/0037-8682-0035-2014
Prevalence of latent tuberculosis and treatment adherence among patients with chronic kidney disease in Campo Grande, State of Mato Grosso do Sul.
Aucely Corrêa Fernandes Chagas (2014)
10.5935/0034-7280.20150024
Nodular scleritis and granulomatous polyangiitis (Wegener) mimicking tuberculosis
C. M. Franco (2015)
10.1155/2012/806198
Aging Adults and Seasonal Influenza: Does the Vitamin D Status (H)Arm the Body?
P. Lang (2012)
10.1179/1973947815Y.0000000043
Vitamin D and tuberculosis: a review on a hot topic
L. Facchini (2015)
10.1016/S1473-3099(12)70275-X
Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis.
A. Ralph (2013)
10.7196/samj.2020.v110i5.14035
Tuberculosis burden in stage 5 chronic kidney disease patients undergoing dialysis therapy at Livingstone Hospital, Port Elizabeth, South Africa.
S. Ndamase (2020)
10.1016/j.cmi.2018.10.009
Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study.
I. Pradipta (2019)
10.5603/PiAP.2016.0013
What factors may influence epidemiological situation of tuberculosis in Poland and in the world?
E. Rowińska-Zakrzewska (2016)
10.1159/000444148
Tolerability and Healthcare Utilization in Maintenance Hemodialysis Patients Undergoing Treatment for Tuberculosis-Related Conditions
A. Hamadah (2016)
10.14745/CCDR.V43I34A01F
L’infection tuberculeuse latente : un aperçu
S. Kiazyk (2017)
10.1016/j.lpm.2017.01.015
Tuberculosis elimination and the challenge of latent tuberculosis.
A. Matteelli (2017)
10.1515/ii-2017-0110
Recent Progress in Diagnosis Methods for Latent Tuberculosis Infection and Its Clinical Applications
L. Zhou (2015)
10.21037/JTD.2020.02.50
Active tuberculosis risk associated with malignancies: an 18-year retrospective cohort study in Korea.
Jaekyung Cheon (2020)
10.14745/CCDR.V43I34A01
Latent tuberculosis infection: An overview.
S. Kiazyk (2017)
10.1016/j.jmii.2020.06.001
Association of vitamin D levels and risk of latent tuberculosis in the hemodialysis population.
S. Lin (2020)
10.1056/NEJMc1508223
Latent Mycobacterium tuberculosis Infection.
H. Getahun (2015)
10.1155/2020/7401541
Prevalence, Clinical Presentation, and Outcome of Tuberculosis in Patients with Chronic Kidney Disease at a Tertiary Care Hospital in Nepal
R. Pradhan (2020)
10.4236/HEALTH.2016.84036
The Role of Zinc in Chronic Kidney Disease Patients on Hemodialysis: A Systematic Review
L. C. Neto (2016)
10.1053/j.ajkd.2012.07.019
Tests for latent tuberculosis in people with ESRD: a systematic review.
T. Rogerson (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar